Harmony Biosciences (HRMY) AI Analysis

HRMY$33.76-0.04 -0.12%
BiotechnologyValue StockGrowth StockHigh Quality
Compare
Market cap$1.98BEnterprise value$1.38BRevenue (TTM)$989.36MMarket position—

Score

74
Bullish
Value
70
Quality
77
Growth
76

Harmony Biosciences Holdings mixes growth with a still-reasonable multiple — Growth 76/100 with P/E 11.2, about 25% below its own multi-year median. Under the hood: P/E 11.2, about 25% below its own multi-year median, plus revenue compounding ~26% annually over recent years. Street targets still imply ~44% upside.

Harmony Biosciences (HRMY) AI Analysis

HRMY price $33.76 -0.04 -0.12%

Ticker
HRMY
Price
$33.76
Change
-0.04 -0.12%
Market cap
$1.98B
P/E
11.04
Forward P/E
9.71
Dividend yield
0.00%
Beta
0.98
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
74
Value
70
Quality
77
Growth
76

Stocklytics score rationale: value 70, quality 77, growth 76.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener